Price T Rowe Associates Inc Exact Sciences Corp Transaction History

Price T Rowe Associates Inc

  • $812 Billion
  • Q1 2025

A detailed history of Price T Rowe Associates Inc transactions in Exact Sciences Corp stock. As of the latest transaction made, Price T Rowe Associates Inc holds 6,403,872 shares of EXAS stock, worth $265 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
6,403,872
Previous 5,760,241 11.17%
Holding current value
$265 Million
Previous $324 Million 14.35%
% of portfolio
0.03%
Previous 0.04%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 14, 2025
BUY
$43.04 - $58.51 $27.7 Million - $37.7 Million
643,631 Added 11.17%
6,403,872 $277 Million
Q4 2024

Feb 14, 2025
BUY
$49.33 - $71.97 $121 Million - $177 Million
2,462,165 Added 74.65%
5,760,241 $324 Million
Q3 2024

Nov 14, 2024
BUY
$42.43 - $70.83 $89.7 Million - $150 Million
2,112,953 Added 178.29%
3,298,076 $225 Million
Q2 2024

Aug 14, 2024
SELL
$41.33 - $74.26 $6.62 Million - $11.9 Million
-160,115 Reduced 11.9%
1,185,123 $50.1 Million
Q1 2024

May 15, 2024
SELL
$56.27 - $73.77 $5.59 Million - $7.33 Million
-99,410 Reduced 6.88%
1,345,238 $92.9 Million
Q4 2023

Feb 14, 2024
SELL
$59.06 - $75.72 $14.1 Million - $18.1 Million
-238,686 Reduced 14.18%
1,444,648 $107 Million
Q3 2023

Nov 14, 2023
SELL
$65.94 - $99.04 $32.9 Million - $49.4 Million
-498,552 Reduced 22.85%
1,683,334 $115 Million
Q2 2023

Aug 14, 2023
BUY
$62.68 - $95.05 $25.2 Million - $38.2 Million
402,314 Added 22.61%
2,181,886 $205 Million
Q1 2023

May 15, 2023
SELL
$47.19 - $70.77 $152 Million - $227 Million
-3,212,795 Reduced 64.35%
1,779,572 $121 Million
Q4 2022

Feb 14, 2023
SELL
$30.35 - $53.15 $24.9 Million - $43.7 Million
-821,810 Reduced 14.13%
4,992,367 $247 Million
Q3 2022

Nov 14, 2022
SELL
$31.97 - $49.37 $307 Million - $474 Million
-9,608,207 Reduced 62.3%
5,814,177 $189 Million
Q2 2022

Aug 15, 2022
SELL
$35.61 - $76.23 $134 Million - $286 Million
-3,757,848 Reduced 19.59%
15,422,384 $607 Million
Q1 2022

May 16, 2022
BUY
$57.56 - $82.54 $310 Million - $445 Million
5,392,099 Added 39.11%
19,180,232 $1.34 Billion
Q4 2021

Feb 14, 2022
SELL
$72.5 - $100.68 $342 Million - $475 Million
-4,716,911 Reduced 25.49%
13,788,133 $1.07 Billion
Q3 2021

Nov 15, 2021
SELL
$90.24 - $124.05 $116 Million - $159 Million
-1,284,299 Reduced 6.49%
18,505,044 $1.77 Billion
Q2 2021

Aug 16, 2021
BUY
$93.66 - $139.27 $140 Million - $208 Million
1,495,404 Added 8.17%
19,789,343 $2.46 Billion
Q1 2021

May 17, 2021
BUY
$116.57 - $155.01 $203 Million - $271 Million
1,745,691 Added 10.55%
18,293,939 $2.41 Billion
Q4 2020

Feb 16, 2021
BUY
$99.61 - $142.12 $1.65 Billion - $2.35 Billion
16,548,248 New
16,548,248 $2.19 Billion

Others Institutions Holding EXAS

# of Institutions
642
Shares Held
160M
Call Options Held
1.69M
Put Options Held
1.42M
View Full List

About EXACT SCIENCES CORP

EXAS Quotes by TradingView
  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $7.33B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Price T Rowe Associates Inc Portfolio

Follow Price T Rowe Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email